Kato, T., Ono, H., Fujii, M., Akahoshi, K., Ogura, T., Ogawa, K., . . . Tanabe, M. (2021). Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells. PLoS One.
Styl ChicagoKato, Tomotaka, et al. "Cytoplasmic RRM1 Activation As an Acute Response to Gemcitabine Treatment Is Involved in Drug Resistance of Pancreatic Cancer Cells." PLoS One 2021.
Citace podle MLAKato, Tomotaka, et al. "Cytoplasmic RRM1 Activation As an Acute Response to Gemcitabine Treatment Is Involved in Drug Resistance of Pancreatic Cancer Cells." PLoS One 2021.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..